Phillip J Yates
Overview
Explore the profile of Phillip J Yates including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yates P, Mehta N, Watson H, Peppercorn A
Virus Res
. 2023 Jan;
325:199039.
PMID: 36610656
Influenza infection causes substantial morbidity and mortality during seasonal epidemics and pandemics. Antivirals, including neuraminidase inhibitors, play an important role in the treatment of severely ill patients infected with influenza....
2.
ODoherty J, Holden K, Johnson A, Cain P, Harding J, Yates P
Ann Vasc Surg
. 2019 Aug;
62:498.e15-498.e17.
PMID: 31449933
Background: Central venous stenosis and occlusion (CVO) is an increasing problem in the growing hemodialysis population. Sequelae include loss of access, loss of sites suitable for future venous access, and...
3.
Heining D, Senior J, Prasad A, Thomas M, Bentall A, Yates P
Oxf Med Case Reports
. 2018 Sep;
2018(10):omy063.
PMID: 30250745
We present a case of angiosarcoma at an arteriovenous fistula site in a non-immunocompromised patient presenting as a soft tissue swelling with associated findings suggestive of lung malignancy, metastases and...
4.
Bradley J, Blumer J, Romero J, Michaels M, Munoz F, Kimberlin D, et al.
Pediatrics
. 2017 Oct;
140(5).
PMID: 29051331
Background: Children with severe influenza infection may require parenteral therapy if oral or inhaled therapies are ineffective or cannot be administered. Results from a study investigating intravenous (IV) zanamivir for...
5.
Marty F, Vidal-Puigserver J, Clark C, Gupta S, Merino E, Garot D, et al.
Lancet Respir Med
. 2017 Jan;
5(2):135-146.
PMID: 28094141
Background: Neuraminidase inhibitors are effective for the treatment of acute uncomplicated influenza. However, there is an unmet need for intravenous treatment for patients admitted to hospital with severe influenza. We...
6.
Yates P, Raimonde D, Zhao H, Man C, Steel H, Mehta N, et al.
Antiviral Res
. 2016 Aug;
134:144-152.
PMID: 27568923
Intravenous zanamivir (IVZ) is a neuraminidase (NA) inhibitor (NAI) under investigation for the treatment of subjects hospitalised with influenza. The study included 130 symptomatic, hospitalised adults with influenza. Subjects received...
7.
Hosgood S, Yates P, Nicholson M
World J Transplant
. 2014 Dec;
4(4):299-305.
PMID: 25540738
Aim: To investigate the effects of 1400W-a selective inducible nitric oxide synthase (iNOS) inhibitor in a model of donation after circulatory death (DCD) kidneys. Methods: Porcine kidneys were retrieved after...
8.
Watanabe A, Yates P, Murayama M, Soutome T, Furukawa H
Antivir Ther
. 2014 Dec;
20(4):415-23.
PMID: 25470818
Background: Zanamivir is a neuraminidase (NA) inhibitor used for the treatment of influenza. There is an unmet need for a parenteral influenza antiviral therapy to treat hospitalized patients. Therefore the...
9.
Marty F, Man C, van der Horst C, Francois B, Garot D, Manez R, et al.
J Infect Dis
. 2013 Aug;
209(4):542-50.
PMID: 23983212
Background: Intravenous zanamivir is a neuraminidase inhibitor suitable for treatment of hospitalized patients with severe influenza. Methods: Patients were treated with intravenous zanamivir 600 mg twice daily, adjusted for renal...
10.
Yates P, Mehta N, Horton J, Tisdale M
Antimicrob Agents Chemother
. 2013 Jan;
57(4):1677-84.
PMID: 23335741
A zanamivir postapproval efficacy study was conducted in children (n = 279) in Japan during three influenza seasons. Pharyngeal swab specimens (n = 714) were obtained for detailed resistance analysis....